The LaserMe is intended for use in dermatological procedures requiring coagulation of soft tissue and skin resurfacing procedures. The LaserMe is further indicated for treatment of benign pigmented lesions, such as, but not limited to lentigines (age spots), solar lentigos (sun spots), melasma, dyschromia, and for treatment of facial wrinkles and fine lines.
NEAUVIA NORTH AMERICA, INC.
100-1600
In Commercial Distribution

  • 00850017374188 ()
100-1600

  • Dermatological solid-state laser system
< 1 >